These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3888810)

  • 1. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.
    Felisart J; Rimola A; Arroyo V; Perez-Ayuso RM; Quintero E; Gines P; Rodes J
    Hepatology; 1985; 5(3):457-62. PubMed ID: 3888810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics.
    Chen TA; Lo GH; Lai KH; Lin WJ
    World J Gastroenterol; 2005 Nov; 11(43):6823-7. PubMed ID: 16425390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.
    Smith CR; Ambinder R; Lipsky JJ; Petty BG; Israel E; Levitt R; Mellits ED; Rocco L; Longstreth J; Lietman PS
    Ann Intern Med; 1984 Oct; 101(4):469-77. PubMed ID: 6089633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis.
    Rimola A; Navasa M; Arroyo V
    Diagn Microbiol Infect Dis; 1995; 22(1-2):141-5. PubMed ID: 7587029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
    Sort P; Navasa M; Arroyo V; Aldeguer X; Planas R; Ruiz-del-Arbol L; Castells L; Vargas V; Soriano G; Guevara M; Ginès P; Rodés J
    N Engl J Med; 1999 Aug; 341(6):403-9. PubMed ID: 10432325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
    Clumeck N; van Laethem Y; Vanhoof R; George C; Rapin M; Butzler JP
    Scand J Infect Dis; 1982; 14(1):57-60. PubMed ID: 6280269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of adenosine deaminase binding protein in neonates treated with tobramycin.
    Gordjani N; Burghard R; Müller D; Mathäi H; Mergehenn G; Leititis JU; Brandis M
    Pediatr Nephrol; 1995 Aug; 9(4):419-22. PubMed ID: 7577399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
    Moore RD; Smith CR; Holloway JJ; Lietman PS
    Arch Intern Med; 1986 Jun; 146(6):1153-7. PubMed ID: 3087307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections.
    Löffler L; Bauernfeind A; Keyl W
    Drugs; 1988; 35 Suppl 7():46-52. PubMed ID: 3265378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.
    Ricart E; Soriano G; Novella MT; Ortiz J; Sàbat M; Kolle L; Sola-Vera J; Miñana J; Dedéu JM; Gómez C; Barrio JL; Guarner C
    J Hepatol; 2000 Apr; 32(4):596-602. PubMed ID: 10782908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics in infections of the biliary tract.
    Muller EL; Pitt HA; Thompson JE; Doty JE; Mann LL; Manchester B
    Surg Gynecol Obstet; 1987 Oct; 165(4):285-92. PubMed ID: 3310282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections.
    Bergeron MG; Mendelson J; Harding GK; Mandell L; Fong IW; Rachlis A; Chan R; Biron S; Feld R; Segal NB
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1231-6. PubMed ID: 3056255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics for spontaneous bacterial peritonitis in cirrhotics.
    Soares-Weiser K; Brezis M; Leibovici L
    Cochrane Database Syst Rev; 2001; (3):CD002232. PubMed ID: 11687020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
    Stromberg BV; Reines HD; Hunt P
    Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous bacterial peritonitis in patients with hepatic cirrhosis: evaluation of a treatment protocol at specialized units.
    Dinis-Ribeiro M; Cortez-Pinto H; Marinho R; Valente A; Raimundo M; Salgado MJ; Ramalho F; Alexandrino P; Carneiro-de-Moura M
    Rev Esp Enferm Dig; 2002 Aug; 94(8):473-81. PubMed ID: 12486852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of the efficacy of treating infections in hematopoietic proliferative diseases: Monotherapy with ceftazidime and tobramycin combined with amoxycillin/ampicillin].
    Koehler M; Bubała H; Sońta-Jakimczyk D; Wieczorek M; Janik-Moszant A; Kuder K
    Pol Tyg Lek; 1990 May 21-28; 45(21-22):417-20. PubMed ID: 2267192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.
    Kuhlmann J; Seidel G; Grötsch H
    Infection; 1982; 10(4):233-9. PubMed ID: 6127319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.
    Navasa M; Follo A; Llovet JM; Clemente G; Vargas V; Rimola A; Marco F; Guarner C; Forné M; Planas R; Bañares R; Castells L; Jimenez De Anta MT; Arroyo V; Rodés J
    Gastroenterology; 1996 Oct; 111(4):1011-7. PubMed ID: 8831596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.